BMC Psychiatry
Effectiveness of Second Generation Antipsychotics: A Systematic Review of Randomized Trials CME

Disclosures

Release Date: June 10, 2008; Valid for credit through June 10, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

  1. Effectiveness of Second Generation Antipsychotics: A Systematic Review of Randomized Trials
    Erik Johnsen, MD
    Hugo A. Jørgensen, PhD, MD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the disadvantages of randomized clinical trials (RCTs) compared with "real-life" natural studies of the efficacy of second-generation antipsychotics (SGAs) for psychosis
  2. Identify the domains for global functioning in patients with psychosis
  3. List SGAs used for the treatment of psychosis
  4. Describe the types of situations for patients with psychosis to best respond to SGAs
  5. List the most common adverse effects of SGAs
Authors and Disclosures

Erik Johnsen, MD
Disclosure: Erik Johnsen, MD, has disclosed no relevant financial relationships.


Hugo A. Jørgensen, PhD, MD
Disclosure: Hugo A. Jørgensen, PhD, MD, has disclosed no relevant financial relationships.


Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.


John Kerr
Disclosure: John Kerr has disclosed no relevant financial relationships.


Bret Stetka, MD
Disclosure: Bret Stetka, MD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.